SCHEMBL172076

SCHEMBL172076

Cc1ccc(CCC(=O)N2CCN(CCC(=O)c3ccc4[nH]c(=O)oc4c3)CC2)cc1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 9/20 0.61
KCNH2 Q12809 2/20 0.59
GRIN2D O15399 1/20 0.57
GRIN3B O60391 1/20 0.57
GRIN1 Q05586 1/20 0.57
GRIN2A Q12879 1/20 0.57
GRIN2B Q13224 1/20 0.57
GRIN2C Q14957 1/20 0.57
GRIN3A Q8TCU5 1/20 0.57
ATXN2 Q99700 2/20 0.51
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HTR1A P08908 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
NOS1 P29475 1/20 0.41
CREBBP Q92793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13137764 0.97 ENPP2 (0.59) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL107143 0.90 ENPP2 (0.59) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL104298 0.88 ENPP2 (0.59) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL105753 0.87 ENPP2 (0.62) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL105299 0.87 GRIN2B (0.62) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL104636 0.86 ENPP2 (0.59) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL3053030 0.85 ENPP2 (0.83) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL109667 0.85 ENPP2 (0.61) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL172121 0.85 GRIN2D (0.55) ENPP2KCNH2GRIN2DGRIN3BGRIN1
SCHEMBL108207 0.83 ENPP2 (0.61) ENPP2KCNH2GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426106-A1 Piperidine and Piperazine derivatives for the treatment of tumours Merck Patent GmbH (DE) 2012-03-07 EP disclosed